The Role of Neurotrophic Factors Conjugated to Iron Oxide Nanoparticles in Peripheral Nerve Regeneration: In Vitro Studies

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ziv Polat, Ofra ^a   Shahar, Abraham ^a   Levy, Itay ^b   Skaat, Hadas ^b   Neuman, Sara ^a   Fregnan, Federica ^c   Geuna, Stefano ^c   Grothe, Claudia ^d,e   Haastert Talini, Kirsten ^d,e   Margel, Shlomo ^b  

^a NVR Research Ltd   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF TURIN   (Italy)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYALURONIC ACID; IRON OXIDE NANOPARTICLE; LAMININ; MYELIN; NANOPARTICLE; NERVE GROWTH FACTOR BETA SUBUNIT; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; NERVE GROWTH FACTOR;

ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; HYDROGEL; IN VITRO STUDY; MYELINATION; NERVE CELL; NERVE REGENERATION; NERVE SPROUTING; PERIPHERAL NERVE; SCHWANN CELL; SPINAL GANGLION; TISSUE CULTURE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; MYELIN SHEATH; PHYSIOLOGY; RAT; TIME; ULTRASTRUCTURE;

ANIMALS; CELLS, CULTURED; FERRIC COMPOUNDS; GANGLIA, SPINAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MYELIN SHEATH; NANOPARTICLES; NERVE GROWTH FACTORS; NERVE REGENERATION; PERIPHERAL NERVES; RATS; TIME FACTORS;

EID: 84918560233     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/267808     Document Type: Article

References (42)

1. G. Lundborg, "Alternatives to autologous nerve grafts, " Handchirurgie, Mikrochirurgie, Plastische Chirurgie, vol. 36, no. 1, pp. 1-7, 2004.
2. C. Grothe, K. Haastert-Talini, T. Freier et al., "BIOHYBRIDBiohybrid templates for peripheral nerve regeneration, " Journal of the PeripheralNervous System, vol. 17, no. 2, pp. 220-222, 2012.
3. Y.-C. Huang and Y.-Y. Huang, "Tissue engineering for nerve repair, " Biomedical Engineering: Applications, Basis and Communications, vol. 18, pp. 100-110, 2006.
4. S. M. Willerth and S. E. Sakiyama-Elbert, "Approaches toneural tissue engineering using scaffolds for drug delivery, " Advanced Drug Delivery Reviews, vol. 59, no. 4-5, pp. 325-338, 2007.
5. K. S. Straley, C. W. P. Foo, and S. C. Heilshorn, "Biomaterial design strategies for the treatment of spinal cord injuries, " Journal of Neurotrauma, vol. 27, no. 1, pp. 1-19, 2010.
6. P. Lu and M. H. Tuszynski, "Growth factors and combinatorial therapies for CNS regeneration, " Experimental Neurology, vol. 209, no. 2, pp. 313-320, 2008.
7. L. Aloe, "Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology, " Trends in Cell Biology, vol. 14, no. 7, pp. 395-399, 2004.
8. S. Varon, J. Nomura, and E. M. Shooter, "Reversible dissociation of the mouse nerve growth factor protein into different subunits, " Biochemistry, vol. 7, no. 4, pp. 1296-1303, 1968.
9. W. Sun, C. Sun, H. Lin et al., "The effect of collagen-binding NGF-β on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model, " Biomaterials, vol. 30, no. 27, pp. 4649-4656, 2009.
10. A. Hoke, T. Ho, T. O. Crawford, C. LeBel, D. Hilt, and J. W. Griffin, "Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers, "The Journal of Neuroscience, vol. 23, no. 2, pp. 561-567, 2003.
11. L. Zhang, Z. Ma, G. M. Smith et al., "GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons, " GLIA, vol. 57, no. 11, pp. 1178-1191, 2009.
12. K. D. Beck, J. Valverde, T. Alexi et al., "Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain, " Nature, vol. 373, no. 6512, pp. 339-341, 1995.
13. S. B. Rangasamy, K. Soderstrom, R. A. E. Bakay, and J. H. Kordower, "Neurotrophic factor therapy for Parkinsons disease, " Progress in Brain Research, vol. 184, pp. 237-264, 2010.
14. R. S. Morrison, A. Sharma, J. de Vellis, and R. A. Bradshaw, "Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture, " Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 19, pp. 7537-7541, 1986.
15. A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin, "Biological roles of fibroblast growth factor-2, " Endocrine Reviews, vol. 18, no. 1, pp. 26-45, 1997.
16. C. Grothe and G. Nikkhah, "The role of basic fibroblast growth factor in peripheral nerve regeneration, " Anatomy and Embryology, vol. 204, no. 3, pp. 171-177, 2001.
17. I. Allodi, L. Casals-Diaz, E. Santos-Nogueira, F. Gonzalez-Perez, X. Navarro, and E. Udina, "FGF-2 low molecular weight selectively promotes neuritogenesis of motor neurons in vitro, " Molecular Neurobiology, vol. 47, no. 2, pp. 770-781, 2013.
18. K. Haastert, E. Lipokatic, M. Fischer, M. Timmer, and C. Grothe, "Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms, " Neurobiology of Disease, vol. 21, no. 1, pp. 138-153, 2006.
19. C. Grothe, K. Haastert, and J. Jungnickel, "Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration-lessons from in vivo studies in mice and rats, " Brain Research Reviews, vol. 51, no. 2, pp. 293-299, 2006.
20. B. Knusel, P. P. Michel, J. S. Schwaber, andF. Hefti, "Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulinlike growth factors I and II, " Journal of Neuroscience, vol. 10, no. 2, pp. 558-570, 1990.
21. H. Skaat, O. Ziv-Polat, A. Shahar, and S. Margel, "Enhancement of the growth and differentiation of nasal olfactorymucosa cells by the conjugation of growth factors to functional nanoparticles, " Bioconjugate Chemistry, vol. 22, no. 12, pp. 2600-2610, 2011.
22. O. Ziv-Polat, H. Skaat, A. Shahar, and S. Margel, "Novel magnetic fibrin hydrogel scaffolds containing thrombin and growth factors conjugated iron oxide nanoparticles for tissue engineering, " International Journal of Nanomedicine, vol. 7, no. 1, pp. 1259-1274, 2012.
23. D. Schubert, "Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cellmitosis, " Journal of Neurobiology, vol. 23, no. 2, pp. 143-148, 1992.
24. S. Zhang and H. Uludag, "Nanoparticulate systems for growth factor delivery, " Pharmaceutical Research, vol. 26, no. 7, pp. 1561-1580, 2009.
25. E. R. Edelman, M. A. Nugent, and M. J. Karnovsky, "Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 4, pp. 1513-1517, 1993.
26. G. F. Whalen, Y. Shing, and J. Folkman, "The fate of intravenously administered bFGF and the effect of heparin, " Growth Factors, vol. 1, no. 2, pp. 157-164, 1989.
27. T. Sakane and W. M. Pardridge, "Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity, " Pharmaceutical Research, vol. 14, no. 8, pp. 1085-1091, 1997.
28. D. N. Ishii and E. M. Shooter, "Regulation of nerve growth factor synthesis in mouse submaxillary glands by testosterone, " Journal of Neurochemistry, vol. 25, no. 6, pp. 843-851, 1975.
29. P. Pradier, I. Jalenques, M. Dalle, R. Reuling, G. Despres, and R. Romand, "Distribution and metabolism patterns of plasma 7Sand β-NGF in the adult male rat, " Journal of Physiology Paris, vol. 88, no. 5, pp. 273-277, 1994.
30. K. Lee, E. A. Silva, and D. J. Mooney, "Growth factor deliverybased tissue engineering: general approaches and a review of recent developments, " Journal of the Royal Society Interface, vol. 8, no. 55, pp. 153-170, 2011.
31. C. C. Berry and A. S. G. Curtis, "Functionalisation of magnetic nanoparticles for applications in biomedicine, " Journal of Physics D Applied Physics, vol. 36, no. 13, pp. R198-R206, 2003.
32. A. Shahar, Z. Nevo, and S. Rochkind, "Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants, " US Patent 0024373, 2001.
33. S. Margel, O. Ziv-Polat, H. Skaat, A. Shahar, and Assignee Bar-Ilan University, "Novel nanocomposite gel and fibrin scaffold for cell implantation and tissue engineering, " Provisional US Patent Application no. 61457989 (7/2011), 61678109 (8/2012), 2012.
34. R. S. Molday and D. Mackenzie, "Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells, " Journal of Immunological Methods, vol. 52, no. 3, pp. 353-367, 1982.
35. H. Skaat, O. Ziv-Polat, A. Shahar, and S. Margel, "Enhanced cell growth by new magnetic scaffolds containing bioactiveconjugated nanoparticles for tissue engineering, " in Applications of Nanomaterials, J. N. Govil, Ed., Studium Press LLC, Houston, Tex, USA, 2012.
36. T. Green-Sadan, Y. Kuttner, T. Lublin-Tennenbaum et al., "Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats, " Experimental Neurology, vol. 194, no. 1, pp. 97-105, 2005.
37. O. Ziv-Polat, M. Topaz, T. Brosh, and S. Margel, "Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles, " Biomaterials, vol. 31, no. 4, pp. 741-747, 2010.
38. G. Shafir, A. Galperin, and S. Margel, "Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment, " Journal of Biomedical Materials Research A, vol. 91, no. 4, pp. 1056-1064, 2009.
39. E. Corem-Salkmon, Z. Ram, D. Daniels et al., "Convectionenhanced delivery of methotrexate-loaded maghemite nanoparticles, " International Journal of Nanomedicine, vol. 6, pp. 1595-1602, 2011.
40. S. Rochklnd, D. El-Ani, Z. Nevo, and A. Shahar, "Increase of neuronal sprouting and migration using 780nm laser phototherapy as procedure for cell therapy, " Lasers in Surgery and Medicine, vol. 41, no. 4, pp. 277-281, 2009.
41. S. Rochkind, A. Shahar, D. Fliss et al., "Development of a tissueengineered composite implant for treating traumatic paraplegia in rats, " European Spine Journal, vol. 15, no. 2, pp. 234-245, 2006.
42. S. Rochkind, L. Astachov, D. El-Ani et al., "Further development of reconstructive and cell tissue-engineering technology for treatment of complete peripheral nerve injury in rats, " Neurological Research, vol. 26, no. 2, pp. 161-166, 2004.